Inventor · disambiguated record
Gal Cafri
Also filed as: CAFRI GAL
4 granted patents·8 pending applications·0 citations·filing 2017–2025
56Inventor score
Files withUS HEALTH7SHEBA IMPACT LTD2DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS1THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES1THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC1
Top patents by PatentIndex Score
12 records- 0177US2025250318A1Hla class ii-restricted t cell receptors against mutated rasTHE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES·Filed 2025·Application pending·0 cites
- 0276US12304940B2HLA class II-restricted t cell receptors against mutated RASUS HEALTH·Filed 2022·Granted May 20, 2025·0 cites·22 claims
- 0372US2025136938A1Methods of enriching cell populations for cancer-specific t cells using in vitro stimulation of memory t cellsTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2024·Application pending·0 cites
- 0470US2023026180A1Hla class i-restricted t cell receptors against mutated rasUS HEALTH·Filed 2022·Application pending·0 cites
- 0569US2024263136A1Methods of preparing an isolated population of dendritic cells and methods of treating cancer using sameUS HEALTH·Filed 2024·Application pending·0 cites
- 0665US11466071B2HLA class I-restricted t cell receptors against mutated RASUS HEALTH·Filed 2018·Granted Oct 11, 2022·0 cites·44 claims
- 0761US12221627B2Methods of enriching cell populations for cancer-specific T cells using in vitro stimulation of memory T cellsUS HEALTH·Filed 2018·Granted Feb 11, 2025·0 cites·11 claims
- 0856US2025353892A1Virus-specific recombinant t cell receptors and t cells comprising themSHEBA IMPACT LTD·Filed 2023·Application pending·0 cites
- 0953US11976299B2Methods of preparing an isolated population of dendritic cells and methods of treating cancer using sameUS HEALTH·Filed 2017·Granted May 7, 2024·0 cites·8 claims
- 1051US2023272038A1Hla class ii-restricted drb t cell receptors against ras with g12d mutationUS HEALTH·Filed 2021·Application pending·0 cites
- 1147US2025319182A1Virus-specific t cells, methods of their preparation and use thereofSHEBA IMPACT LTD·Filed 2023·Application pending·0 cites
- 1242US2021030856A1Cancer immunization platformDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gal Cafri files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →